Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$32.17 USD
+2.36 (7.92%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $32.14 -0.03 (-0.09%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.13 | 0.00% |
Earnings Summary
For their last quarter, Beam Therapeutics (BEAM) reported earnings of -$1.21 per share, beating the Zacks Consensus Estimate of $-1.45 per share. This reflects a positive earnings surprise of 16.55%. Look out for BEAM's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.13 per share, reflecting a year-over-year decrease of 4.63%.
Earnings History
Price & Consensus
Zacks News for BEAM
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
BEAM: What are Zacks experts saying now?
Zacks Private Portfolio Services